Table 3 Univariate-Cox-regression-analysis of known prognostic factors CTAs and NY-BR-1 of breast-cancer patients

Age vs median

0,884

0,530–1,475

0,637

0,987

0,542–1,796

0,966

Tumor grade

1,521

0,930–2,488

0,095

1,652

0,903–3,022

0,104

Tumor stage

1,808

1,241–2,632

0,002

1,988

1,292–3,058

0,002

Lymph node status

2,971

1,730–5,104

0

3,348

1,714–6,537

0

Histological type

0,864

0,672–1,111

0,255

0,855

0,624–1,170

0,327

ER/PR status

0,526

0,307–0,901

0,019

0,775

0,399–1,505

0,451

HER2/neu status

1,064

0,826–1,369

0,632

0,986

0,727–1,337

0,929

MAGE A1 MA454

1,278

0,564–2,898

0,557

2,284

0,910–5,732

0,078

M3H67 reactivity

2,85

1,350–6,017

0,006

4,27

1,834–9,941

0,001

57B reactivity

3,406

1,15–10,03

0,026

3,446

1,00–11,77

0,049

NY-ESO-1 E978

1,272

0,563–2,877

0,563

0,805

0,242–2,684

0,724

GAGE #26

1,988

0,875–4,516

0,101

1,98

0,739–5,303

0,174

MAGE A 6C1

1,65

0,498–5,466

0,413

1,876

0,435–8,087

0,399

NY-BR-1 #5

1,522

0,816–2,839

0,186

1,235

0,554–2,752

0,606